Viewing Study NCT01693159

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:22 PM
Ignite Modification Date: 2026-02-03 @ 9:33 AM
Study NCT ID: NCT01693159
Status: UNKNOWN
Last Update Posted: 2017-09-25
First Post: 2012-09-18
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Effects of ECA on Quality of Life in Head and Neck Cancer Patients Suffering From Cetuximab-induced Rhagades
Sponsor: National Center for Tumor Diseases, Heidelberg
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pain View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Painful cetuximab-induced rhagades View
None Radioimmunotherapy View
None Head and neck cancer View